Request to Join
has invited you to join this group
Discussions
Past Discussions
-
Less than
1 day
left
LeftBegins in
less than
1 day
Begins in
Ended
Ongoing
This discussion centers on using checkpoint inhibitors to manage squamous cell carcinoma of the head and neck (SCCHN).
-
Moderators
-
Professor, hematology & medical oncology and Department of Otolaryngology; Director, Head and Neck Medical Oncology ProgramNabil Saba
Professor, hematology & medical oncology and Department of Otolaryngology; Director, Head and Neck Medical Oncology ProgramProfessor, hematology & medical oncology and Department of Otolaryngology; Director, Head and Neck Medical Oncology Program
-
Experts
-
Associate Director, Moore Cancer Center; Professor of MedicineEzra Cohen
Associate Director, Moore Cancer Center; Professor of MedicineAssociate Director, Moore Cancer Center; Professor of Medicine
-
-
Less than
1 day
left
LeftBegins in
less than
1 day
Begins in
Ended
Ongoing
This discussion will focus on patients with HPV-positive OPSCC who are eligible to receive a de-escalation therapy.
-
Moderators
-
Professor, hematology & medical oncology and Department of Otolaryngology; Director, Head and Neck Medical Oncology ProgramNabil Saba
Professor, hematology & medical oncology and Department of Otolaryngology; Director, Head and Neck Medical Oncology Program
Professor, hematology & medical oncology and Department of Otolaryngology; Director, Head and Neck Medical Oncology Program
-
Experts
-
Assistant Professor at Emory UniversityConor Steuer, MD
Assistant Professor at Emory UniversityAssistant Professor at Emory University
-
Chair of Head and Neck Surgery, Director of the Institute of Head and Neck Studies and Education at the Institute of Cancer and Genomic Sciences, Director of the Institute for Global Innovation at University of BirminghamHisham Mehanna
Chair of Head and Neck Surgery, Director of the Institute of Head and Neck Studies and Education at the Institute of Cancer and Genomic Sciences, Director of the Institute for Global Innovation at University of BirminghamChair of Head and Neck Surgery, Director of the Institute of Head and Neck Studies and Education at the Institute of Cancer and Genomic Sciences, Director of the Institute for Global Innovation at University of Birmingham
-
-
Less than
1 day
left
LeftBegins in
less than
1 day
Begins in
Ended
Ongoing
Based on data revealed during the 2019 SGO Annual Meeting, experts in gynecologic oncology remark on the utilization of targeted therapy for the treatment of patients with epithelial ovarian cancer. Please join us for an installment of our Ask the Experts series as we further...
-
Experts
-
Gynecologic Oncology at University of Miami Health SystemBrian Slomovitz, MD
Gynecologic Oncology at University of Miami Health SystemGynecologic Oncology at University of Miami Health System
-
Obstetrician/Gynecologist at Saint Anthony HospitalKathleen Moore, MD
Obstetrician/Gynecologist at Saint Anthony HospitalObstetrician/Gynecologist at Saint Anthony Hospital
-
Moderators
-
Bringing the global oncology community together.OncLive Community Manager
Bringing the global oncology community together.Bringing the global oncology community together.
-
